SGL Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
SGL Investment Advisors's AMGN Position: Q1 2026 in Review
SGL Investment Advisors reduced its Amgen (AMGN) stake by 0.77% in Q1 2026, selling an estimated $8.91K and leaving 3,215 shares worth $1.06M. The position accounts for 0.4% of the portfolio, ranked #56.
SGL Investment Advisors first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- SGL Investment Advisors held 3,215 shares of Amgen worth $1.06M as of Q1 2026.
- SGL Investment Advisors sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
- Amgen made up 0.4% of SGL Investment Advisors's portfolio in Q1 2026, its #56 holding.
- SGL Investment Advisors first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
- SGL Investment Advisors's Amgen position peaked at $1.19M in Q4 2025.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.